Over 20 groups join Arthritis Australia’s call for urgent action on arthritis and musculoskeletal conditions

September 8, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Arthritis Australia and over 40 leading health stakeholders, including over 20 peak bodies, have issued a formal communique calling for urgent action to provide more affordable evidence-based care for patients. …

Subscribe now to continue reading.

Latest Video

The lesson to learn from the Guild is that you cannot defeat what you do not know
December 14, 2025 - Latest News
Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis
December 15, 2025 - Latest News
Algorae unveils major breakthrough in AI-driven drug combination discovery
December 14, 2025 - Australian Biotech
GBMA to host inaugural summit aimed at addressing medicine shortages
December 15, 2025 - Latest News
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - Latest News

Over 20 groups join Arthritis Australia’s call for urgent action on arthritis and musculoskeletal conditions

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

Algorae unveils major breakthrough in AI-driven drug combination discovery

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

New Stories

The industry is probably right to resist, it just needs to prepare for the response

Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy

Prescient secures European approval to launch PTX-100 trial for rare lymphoma

Orthocell lodges European and UK regulatory application for Remplir

Neuren wins second FDA approval for trofinetide with launch of formulation

Dimerix completes adult recruitment in Phase 3 trial for FSGS treatment DMX-200

Radiopharm Theranostics reports high success rate in Phase 2b imaging trial

Sign In

Over 20 groups join Arthritis Australia’s call for urgent action on arthritis and musculoskeletal conditions

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

Algorae unveils major breakthrough in AI-driven drug combination discovery

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Follow Us

New Stories

The industry is probably right to resist, it just needs to prepare for the response

Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy

Prescient secures European approval to launch PTX-100 trial for rare lymphoma

Orthocell lodges European and UK regulatory application for Remplir

Neuren wins second FDA approval for trofinetide with launch of formulation

Dimerix completes adult recruitment in Phase 3 trial for FSGS treatment DMX-200

Radiopharm Theranostics reports high success rate in Phase 2b imaging trial